Effective treatment of urethritis. A practical guide
- PMID: 1382015
- DOI: 10.2165/00003495-199244020-00005
Effective treatment of urethritis. A practical guide
Abstract
Most cases of urethritis can be readily treated using recommended regimens. The most important causes of urethritis are Chlamydia trachomatis and Neisseria gonorrhoeae, and initial treatment is directed at them. Optimal management requires obtaining a thorough sexual history, evaluation for objective clinical and laboratory evidence of infection, antimicrobial therapy directed towards the major aetiologies, and evaluation and treatment of sexual partners. Treatment of gonorrhoea requires a single-dose regimen active against N. gonorrhoeae, plus a regimen active against C. trachomatis and nongonococcal urethritis. The usually recommended treatment for N. gonorrhoeae is a single dose of ceftriaxone 250mg intramuscularly, but there are many alternatives, including oral ones. Only in very restricted geographical areas and under restricted situations are penicillins still reliable against N. gonorrhoeae. Recommended optimal treatment of C. trachomatis or nongonococcal urethritis currently requires 7 days' treatment with a tetracycline. Some guidelines now propose ofloxacin 300 mg orally twice daily for 7 days as an equivalent alternative, and there are very promising data with a single dose therapy with azithromycin, a long-acting macrolide antimicrobial. Using recommended regimens, microbiological failure is infrequent in compliant patients. Recurrent urethritis is, however, frequent. For patients who receive recommended treatment and do well, no follow-up cultures are needed. Patients with persistent or recurrent symptoms require careful re-evaluation of the patient, documentation of urethritis, and retreatment with antimicrobial agents a second time if urethritis is documented by positive cultures or increased numbers of polymorphonuclear leucocytes in urethral secretions.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Management of Urethritis: Is It Still the Time for Empirical Antibiotic Treatments?Eur Urol Focus. 2019 Jan;5(1):29-35. doi: 10.1016/j.euf.2018.10.006. Epub 2018 Oct 11. Eur Urol Focus. 2019. PMID: 30318465
-
Approach to men with urethritis and urologic complications of sexually transmitted diseases.Med Clin North Am. 1990 Nov;74(6):1543-57. doi: 10.1016/s0025-7125(16)30494-1. Med Clin North Am. 1990. PMID: 2246952 Review.
-
[Male urethritis].Ann Dermatol Venereol. 2016 Nov;143(11):752-755. doi: 10.1016/j.annder.2016.09.015. Epub 2016 Oct 22. Ann Dermatol Venereol. 2016. PMID: 27776813 French. No abstract available.
-
Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study.JAMA. 1995 Aug 16;274(7):545-9. JAMA. 1995. PMID: 7629982 Clinical Trial.
-
Nongonococcal urethritis.Urol Clin North Am. 1984 Feb;11(1):55-64. Urol Clin North Am. 1984. PMID: 6369706 Review.
Cited by
-
Doxycycline vs Hydroxychloroquine + Azithromycin in the Management of COVID-19 Patients: An Open-Label Randomized Clinical Trial in Sub-Saharan Africa (DOXYCOV).Cureus. 2023 Sep 20;15(9):e45619. doi: 10.7759/cureus.45619. eCollection 2023 Sep. Cureus. 2023. PMID: 37868535 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical